Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Leyde

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
JAMA Internal Medicine|May 27, 2020
What Should I Know About Opioids and Living With Chronic Pain?Sarah Leyde, Soraya Azari
Family Practice Management|January 12, 2021
"Quick, Grab the Naloxone": Overdose Preparedness for Ambulatory ClinicsSarah Leyde, Tessa Rife, Irina Kryzhanovskaya
Heart (British Cardiac Society)|May 25, 2021
Weathering the perfect storm: management of heart failure in patients with substance use disordersJacqueline DesJardin, Sarah Leyde, Jonathan Davis
Fungal Genetics and Biology : FG & B|August 5, 2008
Cytoplasmic localization of sterol transcription factors Upc2p and Ecm22p in S. cerevisiaeChelsea Marie, Sarah Leyde, Theodore C White
Journal of General Internal Medicine|August 7, 2025
Response to "Are We Asking Too Much of Primary Care?"Brittany E Blanchard, Elizabeth J Austin, Sarah Leyde
JAMA|January 12, 2026
Methamphetamine Use-ReplySarah Leyde, Alyssa S Tilhou, Judith I Tsui
Journal of General Internal Medicine|January 7, 2022
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case ReportSarah Leyde, Leslie Suen, Lisa Pratt, et al.
JAMA|September 3, 2025
Methamphetamine Use DisorderSarah Leyde, Alyssa S Tilhou, Judith I Tsui
Journal of General Internal Medicine|May 6, 2025
Don't Induct, Just Start Buprenorphine for Opioid Use DisorderJared W Klein, Sarah Leyde, Amy J Kennedy
Journal of Hospital Medicine|November 3, 2021
Things We Do for No Reason™: Prescribing Thiamine, Folate and Multivitamins on Discharge for Patients With Alcohol Use DisorderTriveni DeFries, Sarah Leyde, Lawrence A Haber, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
JAMA Internal Medicine|May 27, 2020
What Should I Know About Opioids and Living With Chronic Pain?Sarah Leyde, Soraya Azari
Family Practice Management|January 12, 2021
"Quick, Grab the Naloxone": Overdose Preparedness for Ambulatory ClinicsSarah Leyde, Tessa Rife, Irina Kryzhanovskaya
Heart (British Cardiac Society)|May 25, 2021
Weathering the perfect storm: management of heart failure in patients with substance use disordersJacqueline DesJardin, Sarah Leyde, Jonathan Davis
Fungal Genetics and Biology : FG & B|August 5, 2008
Cytoplasmic localization of sterol transcription factors Upc2p and Ecm22p in S. cerevisiaeChelsea Marie, Sarah Leyde, Theodore C White
Journal of General Internal Medicine|August 7, 2025
Response to "Are We Asking Too Much of Primary Care?"Brittany E Blanchard, Elizabeth J Austin, Sarah Leyde
JAMA|January 12, 2026
Methamphetamine Use-ReplySarah Leyde, Alyssa S Tilhou, Judith I Tsui
Journal of General Internal Medicine|January 7, 2022
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case ReportSarah Leyde, Leslie Suen, Lisa Pratt, et al.
JAMA|September 3, 2025
Methamphetamine Use DisorderSarah Leyde, Alyssa S Tilhou, Judith I Tsui
Journal of General Internal Medicine|May 6, 2025
Don't Induct, Just Start Buprenorphine for Opioid Use DisorderJared W Klein, Sarah Leyde, Amy J Kennedy
Journal of Hospital Medicine|November 3, 2021
Things We Do for No Reason™: Prescribing Thiamine, Folate and Multivitamins on Discharge for Patients With Alcohol Use DisorderTriveni DeFries, Sarah Leyde, Lawrence A Haber, et al.
Pageof 3